IT-CHEM Faces Delisting Risk Due to Adverse Audit Opinion, Trading Suspended; Q1 Net Loss Continues, CB Issued and Partially Redeemed
[Key Issue] IT-CHEM's external auditor issued a disclaimer of opinion for FY2025, leading to a formal delisting reason under KOSDAQ regulations. Trading was suspended from April 3, 2026, due to audit scope limitations and internal control deficiencies.
[Financial Performance] Q1 2026 consolidated revenue: 12.7B KRW, operating loss of 1.72B KRW, net loss of 4.3B KRW (individual net loss of 2.23B KRW). Losses were exacerbated by financial costs (2.17B) and equity method losses (0.66B).
[Financial Health] Total liabilities 167.2B, equity 61.1B; debt ratio 274%, net debt ratio 243%. In Feb 2026, issued 40B KRW convertible bonds, but on Apr 7 prematurely redeemed 30B, leaving 10B outstanding. Net debt remains high.
[Shareholder Value Impact] Major shareholder Q Investment holds 40.88%. Conversion price on CB is 33,633 won (60% premium to current price). Potential dilution of 1.19M shares (9.3%) partially alleviated by early redemption. No dividends in last 3 years; 288,015 treasury shares (2.2%) held but no cancellation planned.
[AI Summary]IT-CHEM faces imminent delisting risk due to the disclaimer of opinion and trading suspension, which is the most significant drag on the stock price. Persistent losses and high leverage (debt ratio 274%) strain financial stability. Despite growth initiatives in R&D and electronic materials, short-term shareholder value recovery appears challenging.